Tag Archives: big pharma

The Eternal Optimist – Andrew Plump

SpreadLove In Organizations
SpreadLove In Organizations
The Eternal Optimist - Andrew Plump
/

This episode is in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the healthcare ecosystem together. We sat with Andy Plump, President of R&D and Board Member at Takeda, and discussed his personal story, his leadership beliefs, and the “Challenges in Scaling Biotech Innovation” the topic of his panel at the conference. Hear his thoughts on the current and next decades of innovation, “will it be the decades of Life Science or Computer Science?” Most importantly, Andy leaves us with a message of hope. Every dark period in history anchored on the triad of war, pandemic, and social injustice has ended with greatness through science… We are on the edge of this, again, now.

“This decade will be remembered for Life Science or Computer Science… The potential is limitless.“

MEET OUR GUEST Andrew Plump President of Research & Development and Board Member at Takeda.

Dr. Andrew Plum is the President of Research & Development and a Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia.

Andy has been recognized for his contributions to the healthcare industry, education, and the arts. He serves on several non-profit boards including the Board of Trustees for the Boston Symphony Orchestra, the Sarnoff Cardiovascular Research Foundation, the Biomedical Science Careers Program, and as Chairman of the Board of Directors for the PhRMA Foundation.

Prior to Takeda, Andrew served as head of Research & Translational Medicine, deputy to the president of R&D at Sanofi, based in Paris, France. Prior to Sanofi, he served as worldwide cardiovascular research head at Merck.

Andy received his M.D. from the University of California, San Francisco (UCSF), his Ph.D. in cardiovascular genetics, and his B.S. from the Massachusetts Institute of Technology (MIT). He completed a residency in internal medicine and a fellowship in medical genetics at UCSF.

Transcripts

EPISODE TRANSCRIPT: Andrew Plump

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today Andrew Plump President of Research & Development and Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia. Andrew has been recognized for his contributions to…

Work to Make a Difference – Michael Ullmann

SpreadLove In Organizations
SpreadLove In Organizations
Work to Make a Difference - Michael Ullmann
/

Being in healthcare is a privilege and a humbling responsibility; we impact lives. This is what Michael Ullman has done throughout his years at Johnson & Johnson from where he retired recently as Executive VP, General Counsel & Executive Committee Member. Leadership for Mike is grounded in humility, kindness, and optimism, it is above all a responsibility to other people. Hear Mike’s experience leading JNJ to deliver on covid vaccine that saved humanity during the pandemic, and his thoughts on ESG, Health Equity, social responsibility, and how to build high-performing teams to ensure we deliver on our purpose. As leaders, our job is not to be superstars but rather shine through others, through our people’s greatness. Kindness is underused in the world, create a culture that demands it, treat people with respect, trust them, empower them, and help them succeed.

“Kindness is underused. Create a culture that demands it.”

MEET OUR GUEST Michael Ullmann, (Retired) Executive Vice President, General Counsel & Executive Committee Member, Johnson & Johnson

Michael Ullmann retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and Security. 

As General Counsel of the world’s largest Life Sciences company, he successfully guided JNJ through high-profile and high-risk situations, while helping to grow the business to annual sales of $94 billion, increase shareholder value and maintain its reputation as one of the most admired companies in the world. 

Mike joined Johnson & Johnson in 1989 as a mergers & acquisitions attorney and held various management positions, including General Counsel of the Worldwide Medical Devices Group, before becoming the company’s General Counsel in 2012. Michael is a member of the Board of Directors of Americares and serves on the Columbia Law School Board of Visitors. 

Transcripts

EPISODE TRANSCRIPT: Michael Ullmann

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host, joined today by Mike Ullmann. Mike retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and…

Leadership Through Universal Human Truth – Gabi Mittas

SpreadLove In Organizations
SpreadLove In Organizations
Leadership Through Universal Human Truth - Gabi Mittas
/

In this episode, you will hear from an international leader, walking us through her personal journey, starting with her upbringing in Australia in a very cosmopolitan environment, talking about all the diversity and richness you get from growing and thriving in such an atmosphere to her experience in healthcare leading marketing teams in pharma across the world to bring science into something that resonates, touches and impacts people. 

“Align on a common purpose that will drive your behavior… Look for the universal human truth.”

MEET OUR GUEST Gabi Mittas, Chief Marketing Officer Australia, New Zealand, and North Asia Pacific Region at Eli Lilly.

Gabi is one of the most purpose-driven, human-centric leaders you’ll meet. She has an extensive experience in sales, marketing, and commercial organizations across the globe. She led marketing teams in Australia, the UK, the US, and Globally. She was Senior Director in Global Marketing Oncology before taking the lead of the marketing organization as Chief Marketing Officer for Australia, New Zealand, and the North Asia Pacific Region. Gabi is passionate about people’s development and how to positively impact patients’ journeys.

Hope-Driven Leadership – Harout Semerjian

SpreadLove In Organizations
SpreadLove In Organizations
Hope-Driven Leadership - Harout Semerjian
/

In this episode, you’ll be getting a booster shot by hearing from an amazing leader who believes that leadership is a privilege. Harout will give you his recipes of success in building highly engaged and performing teams. You’ll be positively surprised to hear the first ingredient!

“Even if we are standing, the world is turning and changing.”

MEET OUR GUEST Harout Semerjian, President and CEO of GlycoMimetics, a seasoned global pharmaceutical leader with a passion and focus in Oncology. Harout was elected top 10 emerging pharma executives in 2018, a strong believer in leading with care to deliver results for the patients we serve.

Harout is a seasoned biopharmaceutical leader with more than 25 years of expertise in commercializing specialty medicines across the United States, Europe, and emerging markets. He has built a reputation for building high-performance teams, leading transformations, and delivering exceptional results. He has deep expertise in oncology, hematology and rare diseases having launched more than 20 specialty products or major indications over the years. Harout spent 17 years in Novartis where his last role was Senior Vice President and global head of Ribociclib, the CDK4/6 inhibitor. Then he moved to Ipsen to be the Chief Commercial Officer and recently for a short period was the Chief Executive Officer of Immunomedics before its sale to Gilead. Currently, Harout works as a consultant and investor within healthcare.

Harout is passionate about healthcare disparities and coaching talent to achieve their full potential. In his spare time, he spends his time traveling with his family despite having a heavy travel schedule, as it provides an opportunity for his daughters to connect and expand their horizons.